These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
419 related articles for article (PubMed ID: 27429043)
21. Annexin A2 in renal cell carcinoma: expression, function, and prognostic significance. Yang SF; Hsu HL; Chao TK; Hsiao CJ; Lin YF; Cheng CW Urol Oncol; 2015 Jan; 33(1):22.e11-22.e21. PubMed ID: 25284003 [TBL] [Abstract][Full Text] [Related]
22. miR-139-5p suppresses cancer cell migration and invasion through targeting ZEB1 and ZEB2 in GBM. Yue S; Wang L; Zhang H; Min Y; Lou Y; Sun H; Jiang Y; Zhang W; Liang A; Guo Y; Chen P; Lv G; Wang L; Zong Q; Li Y Tumour Biol; 2015 Sep; 36(9):6741-9. PubMed ID: 25833697 [TBL] [Abstract][Full Text] [Related]
23. Identification of Homoharringtonine as a potent inhibitor of glioblastoma cell proliferation and migration. Porcù E; Maule F; Manfreda L; Mariotto E; Bresolin S; Cani A; Bortolozzi R; Della Puppa A; Corallo D; Viola G; Rampazzo E; Persano L Transl Res; 2023 Jan; 251():41-53. PubMed ID: 35788055 [TBL] [Abstract][Full Text] [Related]
24. miR‑378a‑3p inhibits cellular proliferation and migration in glioblastoma multiforme by targeting tetraspanin 17. Guo XB; Zhang XC; Chen P; Ma LM; Shen ZQ Oncol Rep; 2019 Nov; 42(5):1957-1971. PubMed ID: 31432186 [TBL] [Abstract][Full Text] [Related]
25. STAT-1 expression is regulated by IGFBP-3 in malignant glioma cells and is a strong predictor of poor survival in patients with glioblastoma. Thota B; Arimappamagan A; Kandavel T; Shastry AH; Pandey P; Chandramouli BA; Hegde AS; Kondaiah P; Santosh V J Neurosurg; 2014 Aug; 121(2):374-83. PubMed ID: 24878287 [TBL] [Abstract][Full Text] [Related]
26. FOXC2 often overexpressed in glioblastoma enhances proliferation and invasion in glioblastoma cells. Li W; Fu X; Liu R; Wu C; Bai J; Xu Y; Zhao Y; Xu Y Oncol Res; 2013; 21(2):111-20. PubMed ID: 24406047 [TBL] [Abstract][Full Text] [Related]
27. MIEN1, a novel interactor of Annexin A2, promotes tumor cell migration by enhancing AnxA2 cell surface expression. Kpetemey M; Dasgupta S; Rajendiran S; Das S; Gibbs LD; Shetty P; Gryczynski Z; Vishwanatha JK Mol Cancer; 2015 Aug; 14():156. PubMed ID: 26272794 [TBL] [Abstract][Full Text] [Related]
28. Annexin A2 regulates glioma cell proliferation through the STAT3‑cyclin D1 pathway. Chen L; Lin L; Xian N; Zheng Z Oncol Rep; 2019 Jul; 42(1):399-413. PubMed ID: 31115554 [TBL] [Abstract][Full Text] [Related]
29. Coordination of signalling networks and tumorigenic properties by ABL in glioblastoma cells. Lamballe F; Toscano S; Conti F; Arechederra M; Baeza N; Figarella-Branger D; Helmbacher F; Maina F Oncotarget; 2016 Nov; 7(46):74747-74767. PubMed ID: 27732969 [TBL] [Abstract][Full Text] [Related]
30. SLC7A11 Overexpression in Glioblastoma Is Associated with Increased Cancer Stem Cell-Like Properties. Polewski MD; Reveron-Thornton RF; Cherryholmes GA; Marinov GK; Aboody KS Stem Cells Dev; 2017 Sep; 26(17):1236-1246. PubMed ID: 28610554 [TBL] [Abstract][Full Text] [Related]
31. High Mobility Group Box 1 (HMGB1) Predicts Invasion and Poor Prognosis of Glioblastoma Multiforme via Activating AKT Signaling in an Autocrine Pathway. Cheng P; Ma Y; Gao Z; Duan L Med Sci Monit; 2018 Dec; 24():8916-8924. PubMed ID: 30531692 [TBL] [Abstract][Full Text] [Related]
32. The mechanisms of malic enzyme 2 in the tumorigenesis of human gliomas. Cheng CP; Huang LC; Chang YL; Hsieh CH; Huang SM; Hueng DY Oncotarget; 2016 Jul; 7(27):41460-41472. PubMed ID: 27166188 [TBL] [Abstract][Full Text] [Related]
33. γ-Glutamyl transferase 7 is a novel regulator of glioblastoma growth. Bui TT; Nitta RT; Kahn SA; Razavi SM; Agarwal M; Aujla P; Gholamin S; Recht L; Li G BMC Cancer; 2015 Apr; 15():225. PubMed ID: 25884624 [TBL] [Abstract][Full Text] [Related]
34. FKBP9 promotes the malignant behavior of glioblastoma cells and confers resistance to endoplasmic reticulum stress inducers. Xu H; Liu P; Yan Y; Fang K; Liang D; Hou X; Zhang X; Wu S; Ma J; Wang R; Li T; Piao H; Meng S J Exp Clin Cancer Res; 2020 Feb; 39(1):44. PubMed ID: 32111229 [TBL] [Abstract][Full Text] [Related]
35. Flotillin-1 is a prognostic biomarker for glioblastoma and promotes cancer development through enhancing invasion and altering tumour microenvironment. Wang R; Chen Z; Zhang Y; Xiao S; Zhang W; Hu X; Xiao Q; Liu Q; Wang X J Cell Mol Med; 2023 Feb; 27(3):392-402. PubMed ID: 36647700 [TBL] [Abstract][Full Text] [Related]
36. Annexin A2 positively contributes to the malignant phenotype and secretion of IL-6 in DU145 prostate cancer cells. Inokuchi J; Narula N; Yee DS; Skarecky DW; Lau A; Ornstein DK; Tyson DR Int J Cancer; 2009 Jan; 124(1):68-74. PubMed ID: 18924133 [TBL] [Abstract][Full Text] [Related]
37. Tyrosine 23 phosphorylation-dependent cell-surface localization of annexin A2 is required for invasion and metastases of pancreatic cancer. Zheng L; Foley K; Huang L; Leubner A; Mo G; Olino K; Edil BH; Mizuma M; Sharma R; Le DT; Anders RA; Illei PB; Van Eyk JE; Maitra A; Laheru D; Jaffee EM PLoS One; 2011 Apr; 6(4):e19390. PubMed ID: 21572519 [TBL] [Abstract][Full Text] [Related]
38. SEMA6A is a prognostic biomarker in glioblastoma. Zhao J; Tang H; Zhao H; Che W; Zhang L; Liang P Tumour Biol; 2015 Nov; 36(11):8333-40. PubMed ID: 26014517 [TBL] [Abstract][Full Text] [Related]
39. High Podocalyxin levels promote cell viability partially through up-regulation of Annexin A2. San IV; Prost G; Williams JA; Moss SE; Nuber UA Biochem Biophys Res Commun; 2016 Sep; 478(2):573-9. PubMed ID: 27470587 [TBL] [Abstract][Full Text] [Related]
40. Annexin A2 could enhance multidrug resistance by regulating NF-κB signaling pathway in pediatric neuroblastoma. Wang Y; Chen K; Cai Y; Cai Y; Yuan X; Wang L; Wu Z; Wu Y J Exp Clin Cancer Res; 2017 Aug; 36(1):111. PubMed ID: 28814318 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]